Literature DB >> 22424712

Notch-mediated repression of miR-223 contributes to IGF1R regulation in T-ALL.

Samuel Gusscott1, Florian Kuchenbauer, R Keith Humphries, Andrew P Weng.   

Abstract

To identify microRNAs regulated by oncogenic Notch signaling, we performed microarray-based miRNA profiling of T-cell acute lymphoblastic leukemia (T-ALL) cells before and after treatment with γ-secretase inhibitor (GSI) to block Notch signaling. We show miR-223 levels increase after GSI treatment suggesting that active Notch signaling represses miR-223 expression. We also demonstrate that insulin-like growth factor-1 receptor (IGF1R) is regulated by miR-223 in this context, but observe no apparent effects on cell growth by overexpression or knock-down of miR-223 alone. We conclude that miR-223 contributes to IGF1R regulation, but may act in concert with other genes and/or microRNAs to alter T-ALL biology. Crown
Copyright © 2012. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22424712     DOI: 10.1016/j.leukres.2012.02.013

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  20 in total

1.  Notch and NF-kB signaling pathways regulate miR-223/FBXW7 axis in T-cell acute lymphoblastic leukemia.

Authors:  V Kumar; R Palermo; C Talora; A F Campese; S Checquolo; D Bellavia; L Tottone; G Testa; E Miele; S Indraccolo; A Amadori; E Ferretti; A Gulino; A Vacca; I Screpanti
Journal:  Leukemia       Date:  2014-04-14       Impact factor: 11.528

Review 2.  miRNA and TMPRSS2-ERG do not mind their own business in prostate cancer cells.

Authors:  Sundas Fayyaz; Ammad Ahmad Farooqi
Journal:  Immunogenetics       Date:  2013-04-05       Impact factor: 2.846

3.  IGF-IR determines the fates of BCR/ABL leukemia.

Authors:  Jingjing Xie; Xiaoli Chen; Junke Zheng; Chunling Li; Satomi Stacy; Martin Holzenberger; Xuemei Hu; Cheng Cheng Zhang
Journal:  J Hematol Oncol       Date:  2015-02-04       Impact factor: 17.388

Review 4.  Involvement of MicroRNA in T-Cell Differentiation and Malignancy.

Authors:  Najmaldin Saki; Saeid Abroun; Masoud Soleimani; Saeideh Hajizamani; Mohammad Shahjahani; Richard E Kast; Yousef Mortazavi
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2015-01-01

Review 5.  Posttranscriptional regulation of insulin family ligands and receptors.

Authors:  Amaresh C Panda; Ioannis Grammatikakis; Je-Hyun Yoon; Kotb Abdelmohsen
Journal:  Int J Mol Sci       Date:  2013-09-18       Impact factor: 5.923

6.  A parallel-arm phase I trial of the humanised anti-IGF-1R antibody dalotuzumab in combination with the AKT inhibitor MK-2206, the mTOR inhibitor ridaforolimus, or the NOTCH inhibitor MK-0752, in patients with advanced solid tumours.

Authors:  I Brana; R Berger; T Golan; P Haluska; J Edenfield; J Fiorica; J Stephenson; L P Martin; S Westin; P Hanjani; M B Jones; K Almhanna; R M Wenham; D M Sullivan; W S Dalton; A Gunchenko; J D Cheng; L L Siu; J E Gray
Journal:  Br J Cancer       Date:  2014-10-07       Impact factor: 7.640

7.  IGF1R Derived PI3K/AKT Signaling Maintains Growth in a Subset of Human T-Cell Acute Lymphoblastic Leukemias.

Authors:  Samuel Gusscott; Catherine E Jenkins; Sonya H Lam; Vincenzo Giambra; Michael Pollak; Andrew P Weng
Journal:  PLoS One       Date:  2016-08-17       Impact factor: 3.240

Review 8.  Aberrant Signaling Pathways in T-Cell Acute Lymphoblastic Leukemia.

Authors:  Deborah Bongiovanni; Valentina Saccomani; Erich Piovan
Journal:  Int J Mol Sci       Date:  2017-09-05       Impact factor: 5.923

Review 9.  MicroRNA as a Prognostic and Diagnostic Marker in T-Cell Acute Lymphoblastic Leukemia.

Authors:  Katarzyna Gębarowska; Anna Mroczek; Jerzy R Kowalczyk; Monika Lejman
Journal:  Int J Mol Sci       Date:  2021-05-18       Impact factor: 5.923

10.  Notch-regulated miR-223 targets the aryl hydrocarbon receptor pathway and increases cytokine production in macrophages from rheumatoid arthritis patients.

Authors:  Jesús Ogando; Manuel Tardáguila; Andrea Díaz-Alderete; Alicia Usategui; Vanessa Miranda-Ramos; Dannys Jorge Martínez-Herrera; Lorena de la Fuente; María J García-León; María C Moreno; Sara Escudero; Juan D Cañete; María L Toribio; Ildefonso Cases; Alberto Pascual-Montano; José Luis Pablos; Santos Mañes
Journal:  Sci Rep       Date:  2016-02-03       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.